About   Help   FAQ
Phenotypes Associated with This Genotype
Genotype
MGI:5310799
Allelic
Composition
Rbpjtm1Hon/Rbpjtm1.1Hon
Gt(ROSA)26Sortm1(EYFP)Cos/Gt(ROSA)26Sor+
Hes1tm1(cre/ERT2)Lcm/Hes1+
Genetic
Background
involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Gt(ROSA)26Sortm1(EYFP)Cos mutation (24 available); any Gt(ROSA)26Sor mutation (1062 available)
Hes1tm1(cre/ERT2)Lcm mutation (0 available); any Hes1 mutation (23 available)
Rbpjtm1.1Hon mutation (1 available); any Rbpj mutation (191 available)
Rbpjtm1Hon mutation (2 available); any Rbpj mutation (191 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
endocrine/exocrine glands
N
• tamoxifen-treated mice exhibit normal pancreatic ductal morphology and pancreata mass
• tamoxifen-treated mice exhibit a decrease in YFP+ centroacinar cells compared with control mice
• tamoxifen-treated mice exhibit an increase in YFP+ acinar cells compared with control mice
• tamoxifen-treated mice exhibit a rapid transformation of YFP+ centroacinar cells into acinar cells compared with control mice
• however, tamoxifen-treated mice exhibit normal centroacinar and acinar cells proliferation and apoptosis

digestive/alimentary system
• tamoxifen-treated mice exhibit a decrease in YFP+ centroacinar cells compared with control mice
• tamoxifen-treated mice exhibit an increase in YFP+ acinar cells compared with control mice


Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
01/06/2026
MGI 6.24
The Jackson Laboratory